Corrigendum: Intrahepatic infiltration of activated CD8⁺ T cells and mononuclear phagocyte is associated with idiosyncratic drug-induced liver injury

In the published article, there was an error in Figure 3A as published. The X-axis and Y-axis labels of the sixth panel from the top and sixth panel from the bottom in Figure 3A were incorrectly displayed as “FSC-H” and “SSC-A”, respectively.

Figure 3.

Phenotypes of infiltrative immune cells in the DILI livers. (A) Representative flow cytometry result of intrahepatic T cell activation in a patient with DILI. (B) Frequency of activated (CD38⁺HLA-DR⁺) CD8⁺ T cells in patients with DILI was significantly higher than that in healthy donors (p < 0.001). (C) Percentage of activated (CD38⁺HLA-DR⁺) CD8⁺ T cells in DILI livers was positively correlated with serum ALT (r = 0.593, p = 0.036). (D) Representative flow cytometry result of intrahepatic mononuclear phagocyte activation in a patient with DILI. (E) Percentage of activated (CD80⁺) CD14⁺ mononuclear phagocytes in the DILI livers was positively correlated with serum ALT (r = 0.855, p = 0.002). Correlations between variables were analyzed using Spearman or Pearson coefficients. PBMC, peripheral blood mononuclear cell; ALT, alanine aminotransferase.

The correct labels for these panels should be “HLA-DR” and “CD38”, respectively. The corrected Figure 3A and its caption appear below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.